08045804815

TABNCAP HEALTHCARE
GST : 24AAMFT3098D1Z1

Our Products

Ophthalmic Diagnostic Test Strips

Intraocular Lenses

Contact Lenses

Ophthalmic Solutions and Viscoelastics

Vitreoretinal Products

Ophthalmic Machine

Hyaluronic Acid Gel for Dremel

Hyaluronic Acid Gel for Dremel

Absorbable Hemostatic Gelatin Sponge And Powder

Natural Colors Contact Lens

Home Care Products

Skin Care Products

Prolia 60mg Injection

Prolia 60mg Injection Specification

Accuracy
Pharmaceutical grade

Features
Ready-to-use prefilled syringe, single-dose, easy administration

Frequency
Administered once every 6 months

Instruments Type
Injection

Shelf Life
36 months from manufacturing date

Measurement Range
60mg denosumab per 1ml

Function
Inhibits osteoclast-mediated bone resorption

Usage Type
Prescription medication, single-use

Storage Instructions
Store in a refrigerator (2C - 8C). Do not freeze. Protect from light.

Equipment Type
Pharmaceutical Injection

Material
Sterile solution in prefilled syringe

Condition
New and sealed

Technology
Biotechnology-derived monoclonal antibody

Portable
Yes

Wall Mounted
No

Operating Type
Parenteral (Subcutaneous injection)

Use
Treatment of osteoporosis and increased bone loss in adults

Dimension (L*W*H)
Not specified (pre-filled syringe packaging)

Color
Clear to slightly yellow solution

Contraindications
Patients with hypocalcemia

Safety Information
Administer by healthcare professional only. Monitor calcium levels before and during therapy.

Prescription/Non-Prescription
Prescription only

Disposal
Dispose of used syringe safely as per local guidelines

Packaging Size
1 syringe of 1 mL

Brand Name
Prolia

Indications
Osteoporosis in postmenopausal women, bone loss in men at increased risk

Active Ingredient
Denosumab

Excipients
Sorbitol, acetate, polysorbate 20, water for injection, sodium hydroxide (for pH adjustment)

Patient Age Group
Adults

Concentration
60 mg/mL

Container Type
Prefilled single-use syringe

Route of Administration
Subcutaneous

Prolia 60mg Injection Trade Information

Minimum Order Quantity
100 Packs

FOB Port
AHMEDABAD

Payment Terms
Paypal, Cash Advance (CA), Cash in Advance (CID), Letter of Credit at Sight (Sight L/C), Letter of Credit (L/C)

Delivery Time
3 Days

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Box

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Prolia 60mg Injection

Prolia is the brand name for denosumab 60 mg injection, which is used primarily for the treatment of osteoporosis. Like Esentra, it is a monoclonal antibody that works by inhibiting RANKL, a protein that promotes the formation and function of osteoclasts (cells responsible for breaking down bone). By inhibiting RANKL, Prolia helps reduce bone loss and increases bone density, which lowers the risk of fractures, particularly in postmenopausal women and men with osteoporosis.

Prolia is typically administered once every six months as a subcutaneous injection. It is used to:

Treat osteoporosis in postmenopausal women and men at risk of fractures.
Increase bone mass in men receiving hormone ablation therapy for prostate cancer.
Reduce the risk of bone fractures in certain other conditions, such as bone loss due to cancer treatment.

It's important to follow your healthcare provider's instructions regarding dosage and follow-up treatments, as Prolia affects bone turnover. Your doctor will also monitor for side effects and other considerations, like calcium levels, since denosumab can affect calcium metabolism.

If you're receiving or considering Prolia injections, make sure to discuss any concerns with your healthcare provider, particularly regarding the potential for side effects like infections, bone pain, or other reactions.

Targeted Treatment for Bone Loss

Prolia 60mg Injection is specifically designed for adults suffering from osteoporosis and bone loss, particularly postmenopausal women and men at increased risk. By inhibiting osteoclast-mediated bone resorption, Prolia helps to strengthen bones and reduce fracture risk, offering an advanced therapeutic option for those affected by chronic bone weakening conditions.

User-Friendly, Single-Dose Administration

Each Prolia dose comes in a prefilled, single-use syringe for accurate and convenient administration by a healthcare professional. With dosing required only once every six months, it optimizes patient compliance and simplifies osteoporosis management. The syringe's portable and sealed packaging ensures sterility and ease of use within clinical settings.

Safe Handling and Storage Guidelines

For optimal effectiveness, Prolia must be stored in a refrigerator (2C-8C), protected from light and never frozen. Always ensure the used syringe is disposed of according to local medical waste regulations. This maintains patient safety and environmental responsibility while preserving the integrity of this biotechnological medication.

FAQ's of Prolia 60mg Injection:

Q: How is Prolia 60mg Injection administered?

A: Prolia 60mg Injection is administered as a subcutaneous injection, typically in the upper arm, thigh, or abdomen. It must be injected by a healthcare professional using the prefilled single-use syringe.

Q: What is Prolia used for?

A: Prolia is indicated for the treatment of osteoporosis in postmenopausal women and bone loss in men at increased risk. It helps to reduce the risk of bone fractures by inhibiting bone resorption.

Q: When should I receive my Prolia injection?

A: Prolia should be administered once every six months. Your healthcare provider will schedule injections and monitor your treatment progress.

Q: Where should Prolia be stored before use?

A: Prolia must be stored in a refrigerator at 2C to 8C and be protected from light. Do not freeze the medication. Keep it sealed in the original packaging until ready to use.

Q: What is the process for receiving a Prolia injection?

A: Your healthcare provider will verify your calcium levels before administering Prolia. The injection is given subcutaneously, and healthcare staff ensure proper dosing, safe injection technique, and post-injection monitoring.

Q: What are the benefits of using Prolia?

A: Prolia effectively strengthens bone density and reduces the risk of fractures in patients at risk due to osteoporosis or significant bone loss, offering a convenient twice-yearly dosing regimen.

Q: How should I dispose of the used Prolia syringe?

A: After administration, the used syringe must be safely discarded according to local medical waste disposal guidelines to prevent accidental injury or contamination.

Tell us about your requirement